Pharmala Biotech Holdings Inc. (MDMA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 05-2022 | 02-2022 | 11-2021 | 05-2021 | |
| Sales | 71 | 0 | 0 | 0 |
| Cost of Goods | 2 | N/A | N/A | 0 |
| Gross Profit | 69 | N/A | N/A | 0 |
| Operating Expenses | 275 | 285 | 303 | 2,317 |
| Operating Income | -206 | -285 | -303 | -2,317 |
| Pre-tax Income | -206 | -285 | -303 | -2,317 |
| Net Income Continuous | -206 | -285 | -303 | -2,317 |
| Net Income | $-206 | $-285 | $-303 | $-2,317 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | -0.03 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | -0.03 |
| EBITDA(a) | $-206 | $-285 | $-302 | $-2,317 |